SCHEMBL5768309

SCHEMBL5768309

CCOc1nc2cccc(C(=O)OC3CCC(=O)O3)c2n1Cc1ccc(-c2ccccc2N2CC(=O)ON2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAE1 Q13564 4/20 0.49
AGTR2 P50052 3/20 0.49
AGTR1 P30556 3/20 0.49
CYP3A4 P08684 2/20 0.49
ADORA3 P0DMS8 2/20 0.49
ADRA2B P18089 2/20 0.49
SLC6A2 P23975 2/20 0.49
PPARG P37231 2/20 0.49
HTR2B P41595 2/20 0.49
PDE3A Q14432 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
MLNR O43193 1/20 0.49
NR1I2 O75469 1/20 0.49
USP2 O75604 1/20 0.49
ESR1 P03372 1/20 0.49
NR3C1 P04150 1/20 0.49
TP53 P04637 1/20 0.49
PGR P06401 1/20 0.49
ADRB2 P07550 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6849453 0.86 AGTR1 (0.64) AGTR2AGTR1CYP3A4ADORA3ADRA2B
SCHEMBL967294 0.84 AGTR2 (0.66) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL3029695 0.81 AGTR2 (0.69) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL969721 0.73 AGTR2 (0.66) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL3977106 0.71 AGTR2 (0.62) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL18087852 0.70 AGTR2 (0.63) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL3975959 0.69 AGTR1 (0.75) AGTR2AGTR1CYP3A4ADORA3ADRA2B
SCHEMBL7017670 0.69 AGTR2 (0.59) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL683298 0.69 AGTR2 (0.62) NAE1AGTR2AGTR1CYP3A4ADORA3
SCHEMBL1653406 0.69 AGTR2 (0.62) NAE1AGTR2AGTR1CYP3A4ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718641-A2 BENZIMIDAZOLE DERIVATIVE AND ITS USE AS AII RECEPTOR ANTAGONIST Takeda Pharmaceutical Company Limited (JP) 2006-11-08 EP disclosed
WO-2005080384-A2 BENZIMIDAZOLE DERIVATIVE AND USE AS AII RECEPTOR ANTAGONIST TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-01 WO disclosed